MEDICINA
Departamento
Hospital San Pedro de Alcántara
Cáceres, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Pedro de Alcántara (24)
2024
-
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206
2023
-
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Circulation, Vol. 147, Núm. 19, pp. 1436-1443
2022
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
2021
-
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204
2020
-
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664
-
Relationship between clinical control, respiratory symptoms and quality of life for patients with COPD
International Journal of COPD, Vol. 15, pp. 2683-2693
2019
-
Clinical features of women with COPD: Sex differences in a cross-sectional study in Spain (“The ESPIRAL-ES study”)
International Journal of COPD, Vol. 14, pp. 2469-2478
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 102-108
2018
-
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481
-
Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: “The ESPIRAL-ES study”
International Journal of COPD, Vol. 13, pp. 1115-1124
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2017
-
Active smoking and COPD phenotype: Distribution and impact on prognostic factors
International Journal of COPD, Vol. 12, pp. 1989-1999
-
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 53, Núm. 10, pp. 574-582
-
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Hepatology, Vol. 65, Núm. 6, pp. 1810-1822
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
-
«Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease»: A Consensus Document
Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 193-198
2012
-
Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire
Respiratory Research, Vol. 13
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2008
-
Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain
Emerging Infectious Diseases, Vol. 14, Núm. 8, pp. 1259-1262